BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 30, 2017
View Archived Issues
Harpoon Therapeutics completes USD 45M series B financing
Read More
Phase Ib trial of TLD-1433 meets primary and secondary objectives for first 3 patients
Read More
PI3K inhibition shows promise for idiopathic pulmonary fibrosis in GSK-2126458 study
Read More
New mouse model of idiopathic pulmonary fibrosis presented
Read More
Sichuan Kelun-Biotech Biopharmaceutical divulges dipeptidyl peptidase 4 inhibitors
Read More
Shanghai Hansoh Biomedical and collaborator present NS5A HCV inhibitors
Read More
Bayer Pharma discovers MKNK1 inhibitors
Read More
TaiGen Biotechnology submits NDA for Taigexyn intravenous formulation in China
Read More
Heptares Therapeutics identifies muscarinic acetylcholine M1/M4 receptor agonists
Read More
Acerta Pharma presents tyrosine-protein kinase BTK inhibitors
Read More
Trial results support the use of VVZ-149 for postoperative pain
Read More
Biohaven finishes enrollment in study of trigriluzole in patients with spinocerebellar ataxia
Read More
FDA grants fast track designation for AMO-02 as treatment of congenital myotonic dystrophy
Read More
EMA grants PRIME designation for asunercept as treatment of glioblastoma
Read More
Molecular Partners gives additional details on clinical studies of MP-0250
Read More
Novel syndrome associated with first mutation identified in the KCTD15 gene
Read More
Dasiglucagon receives positive opinion for designation as orphan medicinal product
Read More
Array BioPharma and Bristol-Myers enter collaboration for binimetinib and nivolumab combination
Read More
Arcturus Therapeutics receives CFFT funding to advance the development of LUNAR-CF
Read More
Protagonist Therapeutics and Janssen enter into worldwide agreement for PTG-200
Read More
Health Canada grants approval for Resverlogix's clinical trial of apabetalone in Fabry disease
Read More